Charles Schwab’s DaVita DVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.3M Sell
365,569
-18,073
-5% -$3.28M 0.01% 912
2026
Q1
$59M Buy
383,642
+5,113
+1% +$693K 0.01% 1041
2025
Q4
$43M Sell
378,529
-19,633
-5% -$2.39M 0.01% 1253
2025
Q3
$52.9M Sell
398,162
-46,864
-11% -$6.43M 0.01% 1129
2025
Q2
$63.4M Sell
445,026
-23,695
-5% -$3.36M 0.01% 949
2025
Q1
$71.7M Sell
468,721
-20,536
-4% -$3.23M 0.01% 830
2024
Q4
$73.2M Sell
489,257
-12,344
-2% -$1.94M 0.01% 841
2024
Q3
$82.2M Sell
501,601
-45,031
-8% -$6.65M 0.02% 781
2024
Q2
$75.7M Sell
546,632
-12,082
-2% -$1.67M 0.01% 780
2024
Q1
$77.1M Buy
558,714
+18,443
+3% +$2.21M 0.02% 743
2023
Q4
$56.6M Sell
540,271
-23,456
-4% -$2.17M 0.01% 877
2023
Q3
$53.3M Buy
563,727
+14,318
+3% +$1.46M 0.02% 832
2023
Q2
$55.2M Sell
549,409
-5,620
-1% -$521K 0.02% 808
2023
Q1
$45M Buy
555,029
+12,124
+2% +$971K 0.01% 912
2022
Q4
$40.5M Buy
542,905
+22,988
+4% +$1.79M 0.01% 954
2022
Q3
$43M Sell
519,917
-76,036
-13% -$6.67M 0.02% 854
2022
Q2
$47.7M Buy
595,953
+8,076
+1% +$817K 0.02% 777
2022
Q1
$66.5M Sell
587,877
-4,375
-0.7% -$491K 0.02% 701
2021
Q4
$67.4M Sell
592,252
-49,652
-8% -$5.34M 0.02% 719
2021
Q3
$74.6M Buy
641,904
+21,547
+3% +$2.7M 0.02% 639
2021
Q2
$74.7M Buy
620,357
+975
+0.2% +$115K 0.02% 629
2021
Q1
$66.8M Buy
619,382
+18,246
+3% +$2.03M 0.02% 658
2020
Q4
$70.6M Sell
601,136
-11,943
-2% -$1.22M 0.03% 585
2020
Q3
$52.5M Sell
613,079
-54,974
-8% -$4.7M 0.02% 643
2020
Q2
$52.9M Sell
668,053
-44,036
-6% -$3.44M 0.03% 596
2020
Q1
$54.2M Buy
712,089
+13,902
+2% +$1.09M 0.03% 491
2019
Q4
$52.4M Sell
698,187
-32,940
-5% -$2.18M 0.03% 595
2019
Q3
$41.7M Buy
731,127
+100,591
+16% +$5.84M 0.02% 682
2019
Q2
$35.5M Buy
630,536
+32,707
+5% +$1.69M 0.02% 763
2019
Q1
$32.5M Buy
597,829
+37,436
+7% +$2.07M 0.02% 805
2018
Q4
$28.8M Sell
560,393
-13,121
-2% -$840K 0.02% 747
2018
Q3
$41.1M Sell
573,514
-5,824
-1% -$412K 0.03% 633
2018
Q2
$40.2M Sell
579,338
-13,353
-2% -$892K 0.03% 610
2018
Q1
$39.1M Buy
592,691
+5,116
+0.9% +$376K 0.03% 595
2017
Q4
$42.5M Buy
587,575
+14,040
+2% +$864K 0.03% 529
2017
Q3
$34.1M Buy
573,535
+40,514
+8% +$2.44M 0.03% 579
2017
Q2
$34.5M Buy
533,021
+24,035
+5% +$1.59M 0.03% 530
2017
Q1
$34.6M Buy
508,986
+9,962
+2% +$660K 0.03% 514
2016
Q4
$32M Sell
499,024
-11,351
-2% -$707K 0.04% 503
2016
Q3
$33.7M Buy
510,375
+36,917
+8% +$2.6M 0.04% 465
2016
Q2
$36.6M Buy
473,458
+6,719
+1% +$508K 0.05% 401
2016
Q1
$34.3M Buy
466,739
+7,666
+2% +$518K 0.05% 394
2015
Q4
$32M Buy
459,073
+10,284
+2% +$753K 0.04% 414
2015
Q3
$32.5M Buy
448,789
+5,269
+1% +$409K 0.05% 368
2015
Q2
$35.2M Buy
443,520
+6,453
+1% +$530K 0.05% 382
2015
Q1
$35.5M Sell
437,067
-16,021
-4% -$1.23M 0.05% 363
2014
Q4
$34.3M Sell
453,088
-3,126
-0.7% -$235K 0.05% 352
2014
Q3
$33.4M Buy
456,214
+59,050
+15% +$4.32M 0.05% 329
2014
Q2
$28.7M Buy
397,164
+8,576
+2% +$596K 0.05% 377
2014
Q1
$26.8M Buy
388,588
+9,137
+2% +$607K 0.05% 377
2013
Q4
$24M Buy
379,451
+8,394
+2% +$493K 0.05% 380
2013
Q3
$21.4M Buy
371,057
+37,983
+11% +$2.18M 0.04% 388
2013
Q2
$20.2M Buy
+333,074
New +$20.8M 0.05% 377

Other funds holding DVA

Charles Schwab's DVA Position: Q2 2026 in Review

Charles Schwab reduced its DaVita (DVA) stake by 4.7% in Q2 2026, selling an estimated $3.28M and leaving 365,569 shares worth $81.3M. The position accounts for 0.01% of the portfolio, ranked #912.

Charles Schwab first reported a position in DVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $82.2M in Q3 2024. 630 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Charles Schwab held 365,569 shares of DaVita worth $81.3M as of Q2 2026.
  • Charles Schwab sold 18,073 DaVita shares in Q2 2026, an estimated $3.28M.
  • DaVita made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #912 holding.
  • Charles Schwab first reported a position in DaVita in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's DaVita position peaked at $82.2M in Q3 2024.
  • 630 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.